Skip to content

Randomized controlled trial of effects of long-term consumption of milk and dairy products in addition to dietary guidance on metabolic syndrome

Randomized controlled trial of effects of long-term consumption of milk and dairy products in addition to dietary guidance on metabolic syndrome - Randomized controlled trial of long-term consumption of milk and dairy products

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006353
Enrollment
200
Registered
2011-09-15
Start date
2011-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Dietary guidance for 24 weeks Long-term consumption of milk and dairy products in addition to dietary guidance for 24 weeks

Sponsors

Japan Dairy Association
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.BMI >= 25kg/m2 2.Waist >= 85cm 3.Total Cholesterol >= 200mg/dL(nearly equal LDL Cholesterol >= 120mg/dL) 4.Fasting triglyceride >= 150mg/dL 5.Fasting Blood Sugar >= 100mg/dL 6.SBP >= 130mmHg or DBP >= 85mmHg 7.Person who can consume dairy products for 24 weeks. 8.Person who takes antihypertensive drug and/or antihyperlipidemic drug is not excluded on condition that such person has to be reviewed by an investigator.

Exclusion criteria

Exclusion criteria: 1.Smokers 2.Person who suffers health problem from consumption of dairy products, i.e. milk allergy 3.Person whose clinical laboratory test results are significantly out of standard value, and an investigator determined that he is required to take treatment. 4.Person who participated another clinical investigation or trial within 3 months from the start date of this study. 5.Person who has critical disease history such as cardiac disease, cerebrovascular disease, kidney disease and/or diabetic disease. 6.With other factors, an investigator determines that a person is unfit to participate the study.

Design outcomes

Primary

MeasureTime frame
Weight, Waist, Body Fat Percentage, Fasting Blood Sugar, HbA1c, Total Cholesterol, LDL Cholesterol, HDL cholesterol, Fasting Triglyceride, SBP, and DBP, evaluated at the time of registration, 3rd month and 6th month

Secondary

MeasureTime frame
Food frequency questionnaire and questionnaire on exercise and sleeping habit, evaluated at the time of registration, 3rd month and 6th month

Countries

Japan

Contacts

Public ContactAturou Koga

Hubit genomix, Inc. Business Promotion Unit

akoga@hubitgenomix.com03-5148-3992

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026